SEC Form 4 · accession 0001237899-15-000018

REGENERON PHARMACEUTICALS, INC. · REGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Daniel P Van Plew

Officer — SVP & General Mgr Industrial O

Period of report

Feb 20, 2015

Accepted (ET)

Feb 24, 2015 · 5:08 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000872589

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Feb 20, 2015	M	20,000	$21.25	A	38,705	D
Common Stock	Feb 20, 2015	F	1,000	$424.70	D	37,705	D
Common Stock	Feb 20, 2015	F	9,569	$424.70	D	28,136	D
Common Stock^F1	Feb 23, 2015	S	2,300	$426.08	D	25,836	D
Common Stock^F2	Feb 23, 2015	S	1,700	$427.12	D	24,136	D
Common Stock^F3	Feb 23, 2015	S	2,100	$428.27	D	22,036	D
Common Stock^F4	Feb 23, 2015	S	3,331	$429.09	D	18,705	D
Common Stock	holding	—	—		—	1,426	I	By 401(k) Plan

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F5	$21.25	Feb 20, 2015	M	20,000	D	—	Dec 18, 2019	Common Stock	20,000	17,895	D

Explanation of responses

F1Represents volume-weighted average price of sales of 2,300 shares of Company stock on February 23, 2015 at prices ranging from $425.60 to $426.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2015 at each separate price.
F2Represents volume-weighted average price of sales of 1,700 shares of Company stock on February 23, 2015 at prices ranging from $426.63 to $427.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2015 at each separate price.
F3Represents volume-weighted average price of sales of 2,100 shares of Company stock on February 23, 2015 at prices ranging from $427.66 to $428.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2015 at each separate price.
F4Represents volume-weighted average price of sales of 3,331 shares of Company stock on February 23, 2015 at prices ranging from $428.71 to $429.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 23, 2015 at each separate price.
F5The option became exercisable with respect to all shares underlying the option on December 31, 2012, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2012.